What do Ohio insurance plans require before they approve SPRAVATO?

Nearly every plan we reviewed requires prior authorization. The core requirements are consistent: you must be 18 or older, have a documented diagnosis of major depressive disorder, have tried at least two antidepressants at an adequate dose for an adequate length of time without enough improvement, have a baseline depression score from a standardized rating scale, be prescribed SPRAVATO by or in consultation with a psychiatrist, and be treated in a REMS-certified setting with at least two hours of monitoring after each dose. Plans differ on the details, especially how long each antidepressant must have been tried and whether augmentation or psychotherapy is also required.

How many antidepressants do I need to have tried before insurance covers SPRAVATO?

At least two, in every Ohio plan policy we reviewed. Most plans also require the two to come from different drug classes, and most require that the trials happened during your current episode of depression. The minimum length of each trial was six weeks in some policies and eight weeks in others, at a therapeutic or maximally tolerated dose. A few plans additionally require a trial of augmentation therapy or evidence-based psychotherapy.

Do two SSRIs count as two antidepressants for SPRAVATO approval?

Often not. Most Ohio plan policies we reviewed require two antidepressants from different pharmacologic classes. Under those policies, sertraline followed by escitalopram counts as one class, not two. Trying a medication from a second class, such as an SNRI, bupropion, or mirtazapine, would usually be needed. Your prescriber can tell you how your history lines up with your specific plan.

Does psychotherapy count toward SPRAVATO prior authorization?

For some plans it is required, and for some it can substitute for a medication step. Several policies ask whether you have tried psychotherapy when it is available to you, and at least two accept an adequate course of evidence-based therapy such as cognitive behavioral therapy or interpersonal therapy in place of an augmentation trial. Bring the type of therapy, the approximate dates, and the provider's name.

Do I need a psychiatrist to get SPRAVATO approved?

Usually yes. Most plans require that SPRAVATO be prescribed by a psychiatrist or in consultation with one, and at least one Ohio Medicaid policy requires the prescriber to be a psychiatrist. A few accept a mental health provider. Where consultation is allowed, some plans want the consultation notes submitted with the request.

What depression score do I need to qualify for SPRAVATO?

Most plans do not set a single cutoff score, but nearly all require a baseline score on a standardized scale such as the PHQ-9, MADRS, HAM-D, BDI, or QIDS recorded before your first dose. Several describe the depression as needing to be moderate to severe or severe. Some plans define an inadequate response to past antidepressants as 25 percent improvement or less on a rating scale; at least one uses less than 50 percent. The baseline score matters again at renewal, when you must show improvement compared with it.

How long does a SPRAVATO approval last?

It varies widely. Among the Ohio policies we reviewed, the first approval ranged from four weeks to twelve months, most often two to six months. Renewals were typically six or twelve months and required documented improvement on a rating scale. Because the first approval can expire during or shortly after the induction phase, renewal paperwork often needs to start within the first few weeks of treatment.

What can disqualify me from insurance coverage for SPRAVATO?

Besides the FDA label contraindications, plan policies commonly exclude or restrict coverage for people with a moderate or severe substance or alcohol use disorder that is not being treated, active psychosis or a history of psychosis unless the prescriber documents that benefits outweigh risks, pregnancy or breastfeeding, and concurrent ketamine treatment. Some plans also will not cover SPRAVATO alongside electroconvulsive therapy, transcranial magnetic stimulation, vagus nerve stimulation, or deep brain stimulation.

Does my plan require me to take an oral antidepressant with SPRAVATO?

Fewer plans do than before. The FDA approved SPRAVATO as monotherapy for treatment-resistant depression in January 2025, and several Ohio plan policies have since been updated to accept either monotherapy or use with an oral antidepressant. Others do not address it. For the separate indication of depression with acute suicidal ideation or behavior, an oral antidepressant is still required.

SPRAVATO® · Ohio Insurance

SPRAVATO® Insurance Requirements in Ohio

We read the published SPRAVATO coverage criteria of 15 insurers and pharmacy benefit managers that cover Ohio patients. Here is what they agree on, where they differ, and what to gather before your first appointment so approval is not held up.

Request a Benefits Check Call 216-755-4044

Almost every Ohio plan covers SPRAVATO for treatment-resistant depression, and almost every one requires prior authorization first. Approval comes down to whether your records show a handful of specific facts.

The facts plans look for are consistent: at least two antidepressants that did not work well enough, each taken at a proper dose for long enough, a standardized depression score recorded before treatment, and a psychiatrist involved in the prescription.

Where plans differ is in the details: six weeks per medication or eight, whether two drugs from the same class count, and whether therapy or an add-on medication is also required. Those details are what usually delay an approval, and most of them can be sorted out before your first visit.

Prior authorization

Required by nearly every plan reviewed

Antidepressants tried

At least 2, usually from different classes

Length of each trial

6 or 8 weeks, depending on plan

First approval

4 weeks to 12 months, most often 2–6

What nearly every Ohio plan requires

These requirements appeared in essentially every policy we reviewed, across commercial, Medicare Advantage, Ohio Medicaid managed care, and federal plans. If your records cannot show each of these, expect the request to come back.

Age 18 or older. SPRAVATO is not approved for anyone younger.
A documented diagnosis of major depressive disorder, generally according to current DSM criteria. Several plans specify that it be moderate to severe or severe, and some specify that it be without psychotic features.
At least two antidepressants that did not work well enough, each taken at an adequate dose for an adequate length of time. Stopping a medication because of side effects that you could not tolerate generally counts, if it is documented.
A baseline depression score on a standardized scale such as the PHQ-9, MADRS, HAM-D, Beck Depression Inventory, or QIDS, recorded before the first dose.
A psychiatrist involved in the prescription, either as the prescriber or through a documented consultation. A few plans accept another mental health provider.
Treatment in a REMS-certified setting, with at least two hours of monitoring after each dose and blood pressure checked before and after.
No FDA label contraindications: aneurysmal vascular disease or arteriovenous malformation, a history of bleeding in the brain, or an allergy to esketamine or ketamine.

Where Ohio plans differ

This is where most delays come from. The same medication history can meet one plan's criteria and fall short of another's.

Requirement	What we found across Ohio plans
Length of each antidepressant trial	At least 6 weeks in some policies, at least 8 weeks in others. At least one requires the trials to have happened within the past five years.
Different drug classes	Most require the two antidepressants to come from different classes. One Ohio Medicaid policy also requires at least one of them to be an SSRI or SNRI.
Timing	Most require the trials to have happened during your current episode of depression, not years earlier during a different one.
What counts as “didn't work”	Some define it on a rating scale: 25 percent improvement or less in several policies, less than 50 percent in at least one. Others leave it to the prescriber's documentation.
Augmentation or therapy	Several plans also require an add-on (augmentation) trial, such as an antidepressant combined with lithium, thyroid hormone, an antipsychotic, or a second antidepressant, or a course of evidence-based psychotherapy. Others ask whether therapy has been tried where available.
Prescription monitoring check	Several require the prescriber to confirm a check of the state prescription drug monitoring program, which in Ohio is OARRS.
Oral antidepressant	Several policies now accept SPRAVATO on its own or with an oral antidepressant, reflecting the FDA's January 2025 label change. Others do not address it.
Medical or pharmacy benefit	Plans list SPRAVATO under the medical benefit, the pharmacy benefit, or both. Which one applies to you changes who reviews the request and what you pay.

The detail that trips up the most people

Two medications from the same class often count as one trial, not two. Sertraline (Zoloft) followed by escitalopram (Lexapro) are both SSRIs. Under most of the policies we reviewed, that history would still need a medication from a second class, such as an SNRI, bupropion, or mirtazapine.

Plans also do not always count every medication. One Ohio Medicaid policy removed trazodone from its list of qualifying antidepressants. If most of your history involves one class, ask your prescriber how it lines up with your plan before assuming you qualify.

What can stop or limit coverage

Beyond the label contraindications, plan policies commonly restrict coverage when any of the following applies. Several of these are not absolute and depend on what your prescriber documents.

A moderate or severe substance or alcohol use disorder that is not currently being treated or managed
Active psychosis, or a history of psychosis unless the prescriber documents that the benefits outweigh the risks
Pregnancy or breastfeeding
Concurrent ketamine treatment of any kind
Concurrent electroconvulsive therapy, transcranial magnetic stimulation, vagus nerve stimulation, or deep brain stimulation, in some plans
Severe liver impairment, in some plans

If one of these applies to you, it does not necessarily mean the answer is no. It means the request needs to address it directly, and your prescriber should know before it is submitted.

Approval comes in stages

A SPRAVATO approval is rarely open-ended. Among the Ohio policies we reviewed, the first approval ranged from four weeks to twelve months, most often two to six months. That first window often covers only the twice-weekly induction phase and the weeks right after it.

To continue, plans want documented improvement compared with your baseline score, measured on a standardized scale. At least one plan requires the same scale used at baseline, and some want a score recorded within the last one to three months. Renewals were typically approved for six or twelve months at a time.

The practical consequence is that renewal paperwork often has to start within the first few weeks of treatment, and an approval that lapses can interrupt a course that is working. We track each patient's approval dates and submit renewals ahead of them.

Approvals for the separate indication of depression with acute suicidal ideation or behavior are much shorter, typically one to two months, and require an oral antidepressant alongside SPRAVATO.

What to gather before your first appointment

Incomplete medication history delays more SPRAVATO approvals than anything else. A reviewer cannot approve against “tried Zoloft, didn't work.” Everything below can be collected before you see us, and it shortens the process considerably.

Your SPRAVATO prior authorization checklist

Every antidepressant you have taken, with the highest dose you reached, approximate start and stop dates (month and year is enough), and why you stopped: not enough improvement, side effects, or both.
Any add-on medications used alongside an antidepressant, such as lithium, thyroid hormone, aripiprazole, quetiapine, or a second antidepressant, with dates.
Psychotherapy history: the type if you know it (for example, cognitive behavioral therapy), roughly when, for how long, and the therapist or practice.
Other treatments for depression, such as TMS or ECT, with dates and how many sessions.
Your psychiatrist's name and contact information, or the name of the practice where you were last evaluated.
Any recent depression questionnaires you have completed, such as a PHQ-9, if your prescriber has them.
Your insurance card, front and back, including any separate pharmacy card.
If a prescriber you no longer see managed earlier medications, request those records now. They are the slowest piece to obtain.

Writing it down this way gives a reviewer what they need:

Medication	Highest dose	Dates	Why stopped
Sertraline (Zoloft)	150 mg daily	Mar 2025 – Aug 2025	Little improvement after 5 months
Bupropion XL (Wellbutrin)	300 mg daily	Sep 2025 – Jan 2026	Partial improvement, then relapse
Aripiprazole added	5 mg daily	Feb 2026 – May 2026	Restlessness; no meaningful change

This example is illustrative only. It is not a dosing recommendation, and whether a history like this meets criteria depends on your specific plan.

How we handle it

We check your benefits first. Before anything is scheduled, we confirm with your plan whether SPRAVATO is covered, whether it falls under your medical or pharmacy benefit, which criteria apply, and what your cost sharing looks like. We go over what we learn with you by phone. A benefits check is free.
We match your history to your plan's criteria. We compare your records against your plan's current policy, not a generic list, and tell you plainly if something is missing or if your history is unlikely to meet the criteria yet.
We assemble and submit the request. Our staff gathers the documentation, completes the plan's forms, submits, and follows up.
We track renewals and handle appeals. We watch your approval dates and submit renewals before they lapse. If a request is denied, we manage the peer-to-peer review and appeal. Ohio's appeal and external review rights are explained on our SPRAVATO cost and prior authorization page.

These policies change, and yours may differ

Plans revise their criteria regularly, often once a year and sometimes more. Two people with the same insurer can have different requirements depending on whether they are in an individual, employer, Medicare Advantage, or Medicaid plan. Self-funded employer plans frequently use their pharmacy benefit manager's criteria instead. Use this page to understand what to expect, then let a benefits check tell you what applies to you.

Common questions

What do Ohio insurance plans require before approving SPRAVATO?

Prior authorization, in nearly every plan we reviewed. The core requirements are consistent: age 18 or older, a documented diagnosis of major depressive disorder, at least two antidepressants tried at an adequate dose and duration without enough improvement, a baseline depression score, a psychiatrist involved in the prescription, and treatment in a REMS-certified setting with two hours of monitoring. The details differ by plan.

How many antidepressants do I need to have tried?

At least two in every Ohio policy we reviewed. Most require different drug classes and trials during your current episode. Each trial needed to last at least six weeks in some policies and eight in others. A few plans also require an augmentation trial or a course of evidence-based psychotherapy.

Do two SSRIs count as two antidepressants?

Often not. Most policies require two different pharmacologic classes, so sertraline followed by escitalopram counts as one class. A medication from a second class, such as an SNRI, bupropion, or mirtazapine, would usually be needed.

Does psychotherapy count?

For some plans it is required, and for some it can take the place of an augmentation trial. Bring the type of therapy, the approximate dates, and the provider's name.

Do I need a psychiatrist?

Usually. Most plans require SPRAVATO to be prescribed by or in consultation with a psychiatrist, and at least one Ohio Medicaid policy requires a psychiatrist as the prescriber. A few accept another mental health provider. Where consultation is allowed, some plans want the consultation notes submitted.

What depression score do I need?

Most plans do not set one cutoff, but nearly all require a baseline score on a standardized scale such as the PHQ-9 or MADRS before your first dose, and several require the depression to be moderate to severe or severe. That baseline is what your progress is measured against at renewal.

How long does an approval last?

The first approval ranged from four weeks to twelve months across the Ohio policies we reviewed, most often two to six months. Renewals were usually six or twelve months and required documented improvement. Renewal paperwork often needs to start within the first few weeks.

What can disqualify me?

Besides the label contraindications, plans commonly restrict coverage for untreated moderate or severe substance use disorder, active psychosis, pregnancy or breastfeeding, and concurrent ketamine treatment. Some will not cover SPRAVATO alongside ECT, TMS, vagus nerve stimulation, or deep brain stimulation. Several of these depend on documentation rather than being absolute.

Do I have to take an oral antidepressant too?

Fewer plans require it than before. Since the FDA approved SPRAVATO as monotherapy for treatment-resistant depression in January 2025, several Ohio policies accept either approach. For depression with acute suicidal ideation or behavior, an oral antidepressant is still required. More detail is on our cost and prior authorization page.

What if my plan is a self-funded employer plan?

It may use its pharmacy benefit manager's criteria rather than an insurer's standard policy, so requirements can differ from this page. Appeal rights for self-funded plans generally come from federal rules rather than Ohio insurance law. A benefits check will tell you which apply.

Serving Northeast Ohio Communities

CarePoint Infusion Center is in Beachwood just off I-271, roughly 20 minutes from downtown Cleveland. We handle SPRAVATO benefits checks, prior authorizations, renewals, and appeals in-house for patients across the region.

We conveniently serve patients from:

Cleveland Beachwood Hudson Medina Solon Westlake Lakewood Elyria Lorain Parma Strongsville Brecksville Twinsburg Shaker Heights University Heights Lyndhurst South Euclid Mayfield Heights Warrensville Heights Orange Village Pepper Pike Chagrin Falls Akron Fairlawn Cuyahoga Falls Stow Kent Tallmadge Barberton Green Canton Youngstown

And throughout Cuyahoga County and Northeast Ohio. Call (216) 755-4044 to ask about treatment in Beachwood.

Getting started

The fastest way to know whether your plan will approve SPRAVATO is a benefits check against your plan's current policy. Call (216) 755-4044 or send us a message with your insurance information. If you already have your medication history written down, mention it; it speeds everything up.

CarePoint Infusion Center
23215 Commerce Park, Suite 318, Beachwood, OH 44122
Phone (216) 755-4044 · Fax 330-967-0571 · [email protected]
Monday–Thursday 8:00 AM–5:00 PM, Friday 8:00 AM–12:00 PM

If you are in crisis, do not wait for an appointment. Call or text 988, or call 911.

SPRAVATO® cost and prior authorization — what you will pay, assistance programs, and Ohio appeal rights
SPRAVATO® (esketamine) nasal spray — the treatment itself, in detail
Treatment-resistant depression — what the diagnosis means and what options exist
Ketamine therapy that takes insurance — how SPRAVATO and IV ketamine differ on coverage
Prior authorization for infusion therapy — how the approval process works across all our services
SPRAVATO® treatment near Cleveland — location, travel, and the visit schedule

How we compiled this page. In October 2026 we reviewed the SPRAVATO coverage criteria of the 15 insurers and pharmacy benefit managers listed for Ohio in Janssen's payer coverage lookup (data last updated September 29, 2026), and checked a sample against each plan's own published policy document. Those plans include commercial, Medicare Advantage, Ohio Medicaid managed care, and federal and military coverage. We describe requirements in general terms rather than plan by plan, because criteria change often and differ between products from the same insurer. Not every plan that covers SPRAVATO is included in that lookup.

Medical and insurance disclaimer. This page is general education, not medical advice or a guarantee of insurance coverage. Coverage decisions are made by your health plan based on your specific policy and records. Contact your plan or our office to confirm current requirements before relying on them. SPRAVATO carries an FDA boxed warning for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors, and is available only through the SPRAVATO REMS program. It is a prescription treatment requiring a physician order and is not appropriate for everyone. CarePoint Infusion Center does not provide emergency psychiatric services, crisis care, or psychotherapy. If you are having thoughts of harming yourself, call or text 988, call 911, or go to the nearest emergency department.

SPRAVATO® is a registered trademark of Janssen Pharmaceuticals, Inc. CarePoint Infusion Center is an independent provider and is not affiliated with, sponsored by, or endorsed by Janssen Pharmaceuticals or Johnson & Johnson.